Dont tough it out, tell your doctor early so we can adjust the plan and keep you on track
acute post-procedural pain if relevant Diabetes Management (Underlying Etiology) Insulin (long-acting + short-acting) long-term insulin use: Z79.4 GLP-1 agonists (semaglutide, liraglutide), SGLT-2 inhibitors document type of diabetes and complications Metformin type 2 diabetes indicator Chronic Post-Amputation Pharmacology Neuropathic pain agents: Gabapentin, pregabalin, duloxetine phantom limb pain treatment (document G54.6) Tricyclic antidepressants: Amitriptyline phantom pain adjunct Calcitonin: Short-term phantom pain treatment Antiplatelets: Aspirin, clopidogrel ongoing PAD management
How long it takes for Semaglutide GLP-1 to peak can depend on individual health factors, such as the patients starting weight and underlying health conditions
North America led the Wegovy market while holding the largest share of 48% in 2024, primarily due to high obesity rates, a robust healthcare infrastructure, and widespread awareness of innovative obesity treatments
Patients with type 2 diabetes often have comorbidities, such as cardiovascular disease, hepatic disease, or chronic kidney disease
GLP-1 medications slow gastric emptying, allowing intestinal bacteria more time to ferment food and produce gas Gas, bloating, and flatulence are classified as common side effects, though frequency varies between products and individuals Symptoms typically emerge during initial treatment or dose escalation and often improve as the body adapts Dietary modifications, smaller meals, and gradual fibre adjustment can help manage gastrointestinal symptoms Severe abdominal pain, persistent vomiting, or signs of pancreatitis or gallbladder disease require prompt medical attention Table of Contents What Are GLP-1 Medications and How Do They Work
